Evidence map›Paper›PMID 39661188›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2025

Kidney stone disease Practice patterns among urologists in Canada.

Anis Assad, Mahmoud Moustafa, Brendan L Raizenne, Michael Kogon, Jason Y Lee, Michael Ordon, Sero Andonian, Andrea Lantz Powers, Jennifer Bjazevic, Shubha De and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Adoption of thulium fiber laser for lithotripsy A scoping review and bibliometric analysis.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anis AssadDivision of Urology, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada.
Mahmoud MoustafaFaculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
Brendan L RaizenneDivision of Urology, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada.
Michael KogonDivision of Urology, Mackenzie Health, Vaughan, ON, Canada.
Jason Y LeeDivision of Urology, University of Toronto, Toronto, ON, Canada.
Michael OrdonDivision of Urology, University of Toronto, Toronto, ON, Canada.
Sero AndonianDivision of Urology, McGill University, Montreal, QC, Canada.
Andrea Lantz PowersDepartment of Urology, Dalhousie University, Halifax, NS, Canada.
Jennifer BjazevicDepartment of Urology, Schulich School of Medicine and Dentistry, London, ON, Canada.
Shubha DeDivision of Urology, University of Alberta, Edmonton, AB, Canada.
Ben H ChewDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Naeem BhojaniDivision of Urology, Centre hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite kidney stone disease (KSD) guidelines, high-quality evidence for KSD management in Canada is lacking. We aimed to assess Canadian urologists' practice patterns, preferences, and barriers in managing KSD.

methodsA cross-sectional survey was distributed to Canadian urologists via the Canadian Urological Association (CUA), Quebec Urological Association (QUA), and Canadian Endourology Group (CEG), as well as directly to urology departments nationwide. Descriptive statistics were used to analyze the results.

resultsOf 93 respondents, 47% were from academic centers, 43% from community hospitals, and 10% from mixed/private settings. Most performed over 75 ureteroscopies and fewer than 25 percutaneous nephrolithotomies (PCNLs) annually (67% and 58%, respectively). Holmium:YAG (Ho:YAG) lasers were available in 85% of hospitals, thulium fiber laser (TFL) in 70%, and Ho:YAG with Moses effect lasers in 28%. Preferred surgical devices included the TFL (74.5%), followed by the Ho:YAG laser (24.2%) and Ho:YAG with Moses effect laser (21.7%). Endourology fellowship-trained urologists (53%) were more likely to perform their own PCNL access (90% vs. 23%, p<0.001), metabolic workup (73% vs. 48%, p=0.02), and felt more comfortable prescribing prophylactic and medical treatment for KSD (86% vs. 50%, p<0.01) compared to non-endourology fellowship-trained colleagues. Metabolic workup was delegated to nephrologists or specialized clinics by 38%, mainly due to lack of time (25%) and expertise (25%). Additionally, 71% lacked access to multidisciplinary KSD clinics, with 76% believing such clinics would be beneficial.

conclusionsThe study highlights variability in KSD management practices and barriers. Addressing these issues could improve KSD care in Canada and inform future guidelines.

Identifiers

PMID39661188
PMCPMC12091034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.